Breastfeeding reduces hypertension risk

January 30, 2018

A study published in the American Journal of Hypertension indicates that women who breastfeed more children, and for longer periods of time, are less likely to suffer from hypertension after they reach menopause. This is less true of obese women, however.

Elevated blood pressure is the greatest single risk factor for disease and mortality. Evidence from epidemiologic data has also shown the beneficial effects of breastfeeding on the health of infants and their mothers. It has been well documented that long-term breastfeeding is associated with reduced children's allergies, celiac disease, obesity, and diabetes mellitus. However, the effects of breastfeeding on maternal health have been little studied compared with the effects on the children.

Several studies consistently found that absent breastfeeding or premature discontinuation was associated with increased risks of diabetes mellitus, dyslipidemia, metabolic syndrome, coronary heart disease, and cardiovascular diseases. However few studies have established a clear relationship between breastfeeding and hypertension.

This study population comprised 3,119 non-smoking postmenopausal women aged 50 years or older in the 2010-2011 Korea National Health and Nutrition Examination Survey.

More children breastfed and longer duration of breastfeeding were associated with lower risk of hypertension in postmenopausal women, and degree of obesity and insulin resistance moderated the breastfeeding-hypertension association. In particular, the highest quintile of number of children breastfed (5 to 11) showed a 51% lower risk of hypertension compared with the lowest quintile (0 to 1). The highest quintile of duration of breastfeeding (96 to 324 months) showed a 45% lower risk of hypertension.

Although a broad range of chronic diseases are not associated with breastfeeding, some common mechanisms have been proposed to underlie the relationships between breastfeeding and these diseases. First, maternal metabolism (e.g., fat accumulation and insulin resistance) may be "reset" by breastfeeding after pregnancy, which decreases the risk of obesity-related diseases. Second, oxytocin release stimulated by breastfeeding may be associated with the decreased risk of these diseases.

"Our findings endorsed the current recommendations for breastfeeding for the benefit of maternal health in mothers' later lives," said the paper's lead researcher, Nam-Kyong Choi.
-end-
The paper "Breastfeeding and maternal hypertension" is available at: https://academic.oup.com/ajh/article-lookup/doi/10.1093/ajh/hpx219

Direct correspondence to:

Nam-Kyong Choi, B. Pharm., Ph.D
Department of Health Convergence,
Ewha Womans University
Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, South Korea
nchoi@ewha.ac.kr

To request a copy of the study, please contact:

Daniel Luzer
daniel.luzer@oup.com

Sharing on social media? Find Oxford Journals online at @OxfordJournals

Oxford University Press USA

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.